Project Grant K99CA310811
Award Date 7/7/26
Completion Date 6/30/28
Dollars Obligated $126K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Pittsburgh, PA 15222, USA
Similar Awards
- Federal Project Grant Award Summary The University of Pittsburgh received $141,566 in funding through the National Cancer Institute's Cancer Research Manpower program (CFDA 93.398) under a K99/R00 career development award, effective March 24, 2026 through February 28, 2028. This project grant supports research training and workforce development focused on understanding small guanosine triphosphatase (GTPase) proteins, specifically RhoA, and their role in cancer pathogenesis. The research aims to...
- Federal Grant Award Summary The University of Pittsburgh received a $149,804 Project Grant from the National Cancer Institute (NCI) under the Cancer Research Manpower program (CFDA 93.398) awarded March 1, 2025, with completion scheduled for February 28, 2026. This award supports research investigating the impact of LAG3 (Lymphocyte Activation Gene 3) on CD8+ T cell motility and migration in the context of cancer immunotherapy. The research builds upon preliminary findings demonstrating that...
- Federal Project Grant Award Summary The University of Pittsburgh received a $164,190 Project Grant from the National Cancer Institute (NCI) under the Cancer Research Manpower program (CFDA 93.398), awarded January 21, 2026, with completion targeted for July 31, 2029. This award funds research into metastatic breast cancer subclone tracking through an innovative integration of machine learning and comprehensive autopsy data. The project will deliver computational analysis of DNA structural...
- Federal Project Grant Award Summary The University of Pittsburgh received a $261,662 Project Grant from the National Cancer Institute (NCI) under the Cancer Research Manpower program (CFDA 93.398), effective December 1, 2025, with completion scheduled for April 16, 2029. The award funds an integrated in silico and in vivo genetic screening research initiative designed to identify subtype-specific genetic dependencies in hepatocellular carcinoma (HCC). The project employs a hybrid computational...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded the University of Pittsburgh a $214,726 Career Development Project Grant under the Cancer Research Manpower program (CFDA 93.398) effective July 17, 2026, with completion targeted for June 30, 2031. This award supports an investigator's career development in cancer immunology, specifically focusing on transforming growth factor beta (TGF-β) regulation of immune evasion and metastasis in Ewing sarcoma. The primary...
- Federal Grant Award Summary The University of Pittsburgh received a $408,829 Project Grant from the National Cancer Institute (NCI) under the Cancer Biology Research program (CFDA 93.396), effective September 1, 2025 through August 31, 2027. The award supports development of an integrative framework for surface protein imputation in spatial biology applications. The project will advance understanding of tumor microenvironments by creating machine learning approaches to predict surface protein...
- Federal Project Grant Award Summary The University of Pittsburgh received a $151,040 Project Grant award from the National Cancer Institute (NCI) under the Cancer Research Manpower program (CFDA 93.398) effective December 12, 2025, with completion targeted for November 30, 2027. This award supports biomedical training and research development focused on advancing cancer immunotherapy research. Specifically, the grant funds investigation into the relative and synergistic contributions of...
- Federal Grant Award Summary The University of Pittsburgh received a $638,771 Project Grant from the National Cancer Institute (NCI) under the Cancer Biology Research program (CFDA 93.396) effective June 1, 2026, through May 31, 2031. This five-year award funds fundamental research investigating non-canonical functions of the mitochondrial fission protein DRP1 (dynamin-related protein 1) in high-grade serous ovarian cancer (HGSOC). The research focuses on understanding how a DRP1 splice variant...
- The University of Pittsburgh received a $169,982 Project Grant award from the National Cancer Institute under the Cancer Research Manpower program (CFDA 93.398), effective August 8, 2025, through April 30, 2031. The award funds the Program in Cancer Training and Education (PICTE), an intensive research and professional development initiative designed to prepare rising sophomores and juniors for careers in cancer research and oncology. PICTE will enroll ten high-performing undergraduate...
- Federal Grant Award Summary The University of Pittsburgh received a $658,492 Project Grant award from the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395), effective March 18, 2026 through February 28, 2031. This award supports the development of a novel targeted combinatorial therapeutic approach for advanced castration-resistant prostate cancer (ACRPC), including castration-resistant prostate cancer adenocarcinoma (CRPC-ADENO) and neuroendocrine...